Key facts
- It has raised $5.0M; the latest was Angel (individual) ($5.0M) in Mar 2026.
- Notable investors include tech2b.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Pansatori
- ·The full record, as it builds
Funding rounds
No funding rounds for Pansatori are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pansatori
Developer of medical devices and products designed to help patients with the treatment of tinnitus. The company develops a medical technology product with a functional bracket that is easy to use and effectively and sustainably reduces unpleasant ear noises up to silence, enabling patients to help reduce tinnitus stress and enabling peace and relaxation.
- Sector
- Healthcare
- HQ
- Braunau am Inn, Austria
- Founded
- 2019
- Employees
- 6
- Website
- pansatori.com/
- Ownership
- Privately Held (backing)
Pansatori doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pansatori shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pansatori in its N-PORT filings yet. We sweep new filings monthly.